Abstract PD1-06: A Phase 1b Dose-Escalation and Expansion Study of the BCL-2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL-2–positive Metastatic Breast Cancer (MBC)
Cancer research(2019)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined